JP2001089385A - Anti-dental caries agent - Google Patents

Anti-dental caries agent

Info

Publication number
JP2001089385A
JP2001089385A JP26900499A JP26900499A JP2001089385A JP 2001089385 A JP2001089385 A JP 2001089385A JP 26900499 A JP26900499 A JP 26900499A JP 26900499 A JP26900499 A JP 26900499A JP 2001089385 A JP2001089385 A JP 2001089385A
Authority
JP
Japan
Prior art keywords
extract
plaque
agent
dental caries
bacteria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP26900499A
Other languages
Japanese (ja)
Inventor
Makoto Tamesada
誠 爲定
Naomi Kawamura
直美 川村
Kiyoshi Yoshii
記与子 吉井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kobayashi Pharmaceutical Co Ltd
Original Assignee
Kobayashi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kobayashi Pharmaceutical Co Ltd filed Critical Kobayashi Pharmaceutical Co Ltd
Priority to JP26900499A priority Critical patent/JP2001089385A/en
Publication of JP2001089385A publication Critical patent/JP2001089385A/en
Pending legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide an anti-dental caries agent that is inexpensively available and includes the substances safe to human bodies as active ingredients and further provide an anti-teeth-decaying agent that permits not only oral compositions, for example, a mouth-washing solution, to be formulated, but also can be formulated to foods and beverages as an food additive. SOLUTION: The objective anti-dental caries agent comprises, as an active ingredient, the extracts from the dried bark of a cinnamon tree (Cinnamomum cassia Blume), or from cherry tree bark (Prunus jamasakura Siebold). An composition for oral cavity that includes the anti-dental caries agent is provided.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、抗う蝕剤に関す
る。より詳細には、植物の樹皮から抽出されるエキスを
有効成分とする抗う蝕剤に関する。
TECHNICAL FIELD The present invention relates to an anti-carious agent. More specifically, the present invention relates to an anti-carious agent containing an extract extracted from the bark of a plant as an active ingredient.

【0002】[0002]

【従来の技術】う蝕とは一般に虫歯と呼ばれているもの
であり、その原因については次のように考えられてい
る。本来歯には、だ液中の成分である糖タンパク質と口
腔内常在細菌の菌体表層物質との相互作用によりある種
の細菌が吸着している。この細菌は、菌体外に分泌する
酵素であるグルコシルトランスフェラーゼ(以下、「G
Tase」とする。)の作用により、食物由来のショ糖
を粘着性多糖類に変性させ、さらに強固に歯面に付着す
る。これを一般に歯垢と呼ぶが、付着した細菌は、歯垢
中で糖類を代謝し、その代謝産物として酸を生成する。
そしてこの酸が歯のエナメル表面を脱灰しう蝕を進行さ
せる。また歯垢はう蝕の他、口臭の原因となったり、ま
たその進行によっては歯周病、歯肉炎、更には歯槽膿漏
にまで発展するといわれている。
2. Description of the Related Art Caries are generally called caries, and the causes thereof are considered as follows. Naturally, certain kinds of bacteria are adsorbed on teeth due to the interaction between the glycoprotein, which is a component in saliva, and the cell surface substance of bacteria resident in the oral cavity. This bacterium is a glucosyltransferase (hereinafter referred to as "G"), which is an enzyme secreted outside the cells.
Tase ”. ), Food-derived sucrose is denatured into a sticky polysaccharide, and adheres more firmly to the tooth surface. This is generally called plaque, and the attached bacteria metabolize sugars in the plaque and generate an acid as a metabolite thereof.
The acid demineralizes the enamel surface of the tooth and promotes dental caries. It is said that plaque causes not only caries, but also bad breath, and depending on its progress, periodontal disease, gingivitis, and even alveolar pyorrhea.

【0003】[0003]

【発明が解決しようとする課題】本発明の目的の1つ
は、安価に入手でき、人体に安全な物質を有効成分とす
る抗う蝕剤を提供することである。また本発明の第2の
目的は、洗口液や歯磨剤などの口腔用組成物に安全に配
合できるだけでなく、食品添加物として飲食物にも配合
可能な物質を有効成分とする抗う蝕剤を提供することで
ある。また、本発明の第3の目的は、歯垢の生成を抑制
することによって、口臭や歯周病、歯肉炎並びに歯槽膿
漏といった口腔疾患を予防するのに有用な抗う蝕剤を提
供することである。
An object of the present invention is to provide an anti-cariogenic agent which is available at a low cost and contains a substance which is safe for the human body as an active ingredient. A second object of the present invention is to provide an anti-cariogenic agent comprising, as an active ingredient, a substance which can be safely blended into an oral composition such as a mouthwash or a dentifrice, and which can be blended into food or drink as a food additive. It is to provide. A third object of the present invention is to provide an anti-cariogenic agent which is useful for preventing oral diseases such as bad breath, periodontal disease, gingivitis and alveolar pyorrhea by suppressing the formation of plaque. It is.

【0004】[0004]

【課題を解決するための手段】本発明者は、上記事情に
鑑みて、う蝕や歯周疾患の予防に好適であって人体に安
全な抗う蝕剤を求めて日夜鋭意研究を重ねていたとこ
ろ、食品添加剤の一種であるケイヒ並びにオウヒの抽出
物に、S.mutans 菌及び S.sobrinus 菌が歯に付着する
のを有意に防止する作用があることを見出し、抗う蝕剤
として有効であることを確認した。本発明は、かかる知
見に基づいて完成されたものである。
SUMMARY OF THE INVENTION In view of the above circumstances, the present inventor has conducted intensive studies day and night in search of an anti-caries agent which is suitable for prevention of caries and periodontal disease and which is safe for the human body. However, it has been found that extracts of cauliflower and spruce , which are a kind of food additive, have an effect of significantly preventing S. mutans and S. sobrinus from adhering to teeth, and are effective as an anti-cariogenic agent. Confirmed that there is. The present invention has been completed based on such findings.

【0005】すなわち、本発明はケイヒまたはオウヒと
いった植物樹皮の抽出物を有効成分として含有する抗う
蝕剤である。
That is, the present invention is an anti-cariogenic agent containing an extract of plant bark such as cinnamon or spruce as an active ingredient.

【0006】また本発明は上記抗う蝕剤を含有する口腔
用組成物(飲食物を含む)である。
The present invention is also an oral composition (including food and drink) containing the above-mentioned anti-carious agent.

【0007】[0007]

【発明の実施の形態】本発明の抗う蝕剤の有効成分とし
て用いられるケイヒ(桂皮)はクスノキ科クスノキ属の
Cinnamomum ccassia Blume、その近縁植物の枝からは
ぎ取られた樹皮であり、またオウヒ(桜皮)はバラ科サ
クラ属のヤマザクラPrunus jamasakura Siebold、また
はその近縁植物(Rosaceae)の樹皮である。本発明にお
いてはこれらの溶媒抽出物が好適に用いられる。
BEST MODE FOR CARRYING OUT THE INVENTION The cinnamon (cinnamon bark) used as an active ingredient of the anti-cariogenic agent of the present invention is a member of the camphor family, Camphor Tree
Cinnamomum ccassia Blume, a bark peeled off from a branch of a closely related plant, and spruce (cherry bark) is a bark of Prunus jamasakura Siebold of the genus Rosaceae, or a closely related plant (Rosaceae). In the present invention, these solvent extracts are suitably used.

【0008】これらの樹皮はそのまま若しくは破砕物と
して抽出操作に付してもよいし、また乾燥後、必要に応
じて粉砕粉体状として抽出操作に付してもよい。
The bark may be subjected to an extraction operation as it is or as a crushed product, or after drying, may be subjected to an extraction operation as a pulverized powder if necessary.

【0009】抽出溶媒としては、例えば、水、メタノー
ル,エタノール,プロパノール及びブタノール等の炭素
数1〜4の低級アルコール;酢酸エチルエステル等の低
級アルキルエステル;エチレングリコール、ブチレング
リコール、プロピレングリコール、グリセリンなどのグ
リコール類;その他エチルエーテル、アセトン、酢酸等
の極性溶媒;ベンゼンやヘキサン等の炭化水素;エーテ
ルや石油エーテルなどのエーテル類等の非極性溶媒の公
知の有機溶媒を挙げることができる。これら溶媒は、単
独で用いてもよく、二種以上を組み合わせて使用するこ
ともできる。例えば脂肪分の多い原料などの場合は、必
要に応じて有機溶媒に適量な水を加えて含水有機溶媒と
して用いることもできる。本発明において好ましくは、
エタノール等のアルコール類または20〜40重量%エ
タノール水溶液など含水アルコール溶液を用いることが
できる。
Examples of the extraction solvent include water, lower alcohols having 1 to 4 carbon atoms such as methanol, ethanol, propanol and butanol; lower alkyl esters such as ethyl acetate; ethylene glycol, butylene glycol, propylene glycol, glycerin and the like. Other known organic solvents such as glycols; other polar solvents such as ethyl ether, acetone and acetic acid; hydrocarbons such as benzene and hexane; and nonpolar solvents such as ethers such as ether and petroleum ether. These solvents may be used alone or in combination of two or more. For example, in the case of a raw material having a high fat content, an appropriate amount of water can be added to an organic solvent as needed to be used as a water-containing organic solvent. In the present invention, preferably,
Alcohols such as ethanol or aqueous alcohol solutions such as 20 to 40% by weight aqueous ethanol solution can be used.

【0010】抽出方法としては、一般に用いられる方法
を採用することができる。制限はされないが、例えば溶
媒中に樹皮(そのまま若しくは粗末、細切物)、又はそ
れらの乾燥破砕物(粉末など)を冷浸、温浸等によって
浸漬する方法、加温し攪拌しながら抽出を行い、濾過し
て抽出液を得る方法、またはパーコレーション法等を挙
げることができる。得られた抽出液は、必要に応じてろ
過または遠心分離によって固形物を除去した後、使用の
態様により、そのまま用いるか、または溶媒を留去して
一部濃縮若しくは乾燥して用いてもよい。また濃縮乃至
は乾燥後、該濃縮乃至は乾燥物を非溶解性溶媒で洗浄し
て精製して用いても、またこれを更に適当な溶剤に溶解
もしくは懸濁して用いることもできる。また、抽出液
を、慣用されている精製法、例えば向流分配法や液体ク
ロマトグラフィー等を用いて、グルコシルトランスフェ
ラーゼ阻害活性を有する画分を取得、精製して使用する
ことも可能である。更に、本発明においては、例えば、
上記のようにして得られた溶媒抽出液を、減圧乾燥、凍
結乾燥等の通常の手段により植物エキス乾燥物として使
用することもできる。
As an extraction method, a generally used method can be adopted. Although there is no limitation, for example, a method of immersing bark (as is or coarse powder, finely chopped material) or a dried and crushed product thereof (powder, etc.) in a solvent by cold immersion, digestion, etc. And a method of obtaining an extract by filtration and percolation. The obtained extract may be used after removal of solids by filtration or centrifugation as necessary, depending on the mode of use, or may be used as it is, or may be partially concentrated or dried by evaporating the solvent. . After concentration or drying, the concentrated or dried product may be washed with an insoluble solvent and purified for use, or it may be further dissolved or suspended in a suitable solvent for use. In addition, a fraction having glucosyltransferase inhibitory activity can be obtained and purified from the extract using a conventional purification method, for example, a countercurrent distribution method or liquid chromatography, and used. Further, in the present invention, for example,
The solvent extract obtained as described above can also be used as a dried plant extract by ordinary means such as drying under reduced pressure and freeze drying.

【0011】なお、ケイヒ及びオウヒ抽出物は、いずれ
もエキスや流エキス剤などといった医薬品原料として、
また食品添加物として商業的に販売されているものであ
る。従って、本発明においては簡便にはそれらを用いる
こともできる。
[0011] Both cinnamon and spruce extracts are used as pharmaceutical raw materials such as extracts and liquid extracts.
It is also commercially sold as a food additive. Therefore, in the present invention, they can be used simply.

【0012】本発明の抗う蝕剤は、上記のケイヒまたは
オウヒの抽出物を有効成分として含有するものであり、
食品、医薬部外品又は医薬品などの各種口腔用組成物の
成分として配合されることにより、口腔内の歯垢生成の
防止に有効に利用することができる。なお、ここで口腔
用組成物とは、例えば飲食物のように経口的に摂取され
るもの並びに歯磨きやマウスウォッシュのように口腔内
で用いられるものの双方を含むものである。
The anti-caries agent of the present invention contains the above extract of calyx or spruce as an active ingredient,
By being blended as a component of various oral compositions such as foods, quasi-drugs, and pharmaceuticals, it can be effectively used to prevent plaque formation in the oral cavity. Here, the oral composition includes both those that are taken orally, such as food and drink, and those that are used in the oral cavity, such as toothpaste and mouthwash.

【0013】口腔用組成物として具体的には、例えばト
ローチ、チューインガム、キャンディ、グミキャンデ
ィ、チョコレート、ジュース等の各種食品;歯磨剤(練
り状、液体状、粉末固形状),マウススプレーなどの口
中清涼剤、咀嚼剤、トローチ剤、口腔用パスタ剤、うが
い剤、シロップ剤等の医薬品又は医薬部外品;歯磨剤、
マウスウォッシュ、マウスリンスなどの口腔内化粧品を
挙げることができる。好ましくは、トローチ、チューイ
ンガム及びキャンディ等の食品、並びに歯磨剤,マウス
ウォッシュ及びマウスリンスなどの洗口剤を挙げること
ができる。
Specific examples of the oral composition include various foods such as troches, chewing gums, candy, gummy candy, chocolate, juice, etc .; dentifrice (paste, liquid, powder solid), mouth spray such as mouse spray, etc. Pharmaceutical or quasi-drugs such as fresheners, chewing agents, lozenges, oral pasta, gargles, syrups; dentifrices
Oral cosmetics such as mouthwash and mouth rinse can be mentioned. Preferably, foods such as troches, chewing gums and candy, and mouthwashes such as dentifrices, mouthwashes and mouth rinses can be mentioned.

【0014】これらの形態並びに剤形は、特に制限され
ず、種類に応じて任意に定めることができる。
[0014] These forms and dosage forms are not particularly limited, and can be arbitrarily determined according to the type.

【0015】本発明の抗う蝕剤の適用濃度は、口腔用組
成物の種類、ケイヒまたはオウヒの抽出物の有効濃度、
口中における希釈などの因子を考慮して適宜選択決定す
ることができる。好適な濃度として、ケイヒ抽出液(ケ
イヒ乾燥物換算1g/ml)の場合、口腔用組成物10
0重量%あたり0.3〜10重量%、特に0.5〜5重
量%の範囲を挙げることができる。またオウヒ抽出液
(オウヒ乾燥物換算1g/ml)の場合、0.5〜10
重量%、特に1〜5重量%の範囲を挙げることができ
る。
The application concentration of the anti-carious agent of the present invention depends on the type of the oral composition, the effective concentration of the extract of cinnamon or spruce,
It can be appropriately selected and determined in consideration of factors such as dilution in the mouth. As a preferable concentration, in the case of a cinnamon extract (1 g / ml in terms of dried cinnamon), the oral composition 10
The range is 0.3 to 10% by weight, particularly 0.5 to 5% by weight per 0% by weight. In the case of spruce extract (1 g / ml in terms of dried spruce), 0.5 to 10
% By weight, in particular from 1 to 5% by weight.

【0016】本発明の抗う蝕剤は、本発明の効果を妨げ
ない限り、他の成分として、公知若しくは将来公知とな
り得る、S.mutans 菌ないしはS.sobrinus 菌に対する抗
菌剤、これらの菌の歯面への付着防止剤または抗GTas
e剤等の抗う蝕剤、若しくは消炎剤などの成分と組み合
わせて配合することもできる。
The anti-cariogenic agent of the present invention is known or may be known in the future as an antibacterial agent against S. mutans or S. sobrinus , as long as the effects of the present invention are not impaired. Anti-adhesion agent to surface or anti-GTas
It can also be compounded in combination with components such as anti-caries agents such as e-agents or anti-inflammatory agents.

【0017】また、本発明の抗う蝕剤は、適用する口腔
用組成物の種類に応じて、該口腔用組成物に通常配合さ
れる成分と併用することができる。
The anti-caries agent of the present invention can be used in combination with a component usually blended in the oral composition, depending on the type of the oral composition to be applied.

【0018】例えば練歯磨の場合、第2リン酸カルシウ
ム、炭酸カルシウム、不溶性メタリン酸ナトリウム、非
晶質シリカ、酸化アルミニウム等の研磨剤;カルボキシ
メチルセルロース、ヒドロキシエチルセルロース、アル
ギン酸塩、カラゲナン、アラビアゴム、ポリビニルアル
コール等の粘結剤;ポリエチレングリコール、ソルビト
ール、グリセリン、プロピレングリコール等の粘稠剤;
ラウリル硫酸ナトリウム、ドデシルベンゼンスルホン酸
ナトリウム、水素添加ココナッツ脂肪酸モノグイセリド
モノ硫酸ナトリウム、ラウリルスルホ酢酸ナトリウム、
N−ラウロイルザルコシン酸ナトリウム、N−アシルグ
ルタミン酸塩、ショ糖脂肪酸エステル等の発泡剤等を挙
げることができ、更にこれに通常用いられるメントール
等の香料並びに矯味剤又は甘味剤、防腐剤等を配合する
ことができる。マウスウオッシュ等の洗口剤並びにチュ
ーイングガム等の食品の場合についても、常法の成分を
併用することができる。なお、併用配合される甘味剤と
しては、う蝕性が低いか又はないものが好ましく、例え
ばD−キシロース、キシリトール、サッカリンナトリウ
ム、アスパルテーム、トレハロースなどを好適に挙げる
ことができる。
For example, in the case of toothpaste, abrasives such as dibasic calcium phosphate, calcium carbonate, insoluble sodium metaphosphate, amorphous silica and aluminum oxide; carboxymethylcellulose, hydroxyethylcellulose, alginate, carrageenan, gum arabic, polyvinyl alcohol, etc. Binders such as polyethylene glycol, sorbitol, glycerin, propylene glycol;
Sodium lauryl sulfate, sodium dodecylbenzene sulfonate, hydrogenated coconut fatty acid sodium monoglyceride monosulfate, sodium lauryl sulfoacetate,
Foaming agents such as sodium N-lauroyl sarcosinate, N-acyl glutamate, sucrose fatty acid esters and the like can be mentioned. Further, flavoring agents such as menthol and flavoring or sweetening agents, preservatives and the like which are usually used therefor can be used. Can be blended. In the case of mouthwashes such as mouthwashes and foods such as chewing gum, conventional ingredients can be used in combination. In addition, as a sweetener combined and used, those with low or no caries are preferable, and for example, D-xylose, xylitol, saccharin sodium, aspartame, trehalose and the like can be suitably mentioned.

【0019】さらに、本発明の抗う蝕剤は、塩化リゾチ
ーム、溶菌酵素、デキストラナーゼ、ムタナーゼ、クロ
ルヘキシジン、ソルビン酸、アレキシジン、ヒノキチオ
ール、セチルピリジニウム、アルキルグリシン、アルキ
ルジアミノエチルグリシン塩、モノフルオロリン酸ナト
リウム、フッ化ナトリウム、フッ化第1スズ、水溶性第
一若しくは第二リン酸塩、第四級アンモニウム化合物、
塩化ナトリウム等の成分と併用して用いることもでき
る。
Further, the anti-caries agent of the present invention includes lysozyme chloride, lytic enzyme, dextranase, mutanase, chlorhexidine, sorbic acid, alexidine, hinokitiol, cetylpyridinium, alkylglycine, alkyldiaminoethylglycine salt, monofluorophosphate Sodium, sodium fluoride, stannous fluoride, water-soluble primary or secondary phosphate, quaternary ammonium compound,
It can be used in combination with components such as sodium chloride.

【0020】[0020]

【実施例】以下、試験例及び実施例により本発明をより
詳細に説明するが、本発明はかかる実施例によって何ら
制限されるものではない。試験例 (1)歯垢(菌)付着抑制試験 (a)ケイヒ抽出物 ケイヒ抽出物の抗う蝕作用を、下記に記載する歯垢
(菌)付着抑制試験により評価した。なお、歯垢(菌)
付着試験は歯面の代わりにガラス試験管を用いて行っ
た。
The present invention will be described in more detail with reference to the following Test Examples and Examples, which should not be construed as limiting the present invention. Test Example (1) Plaque (Bacterial) Adhesion Inhibition Test (a) Caulis Extract The anti-cariogenic effect of the caulis extract was evaluated by the plaque (fungus) adhesion inhibition test described below. In addition, plaque (fungus)
The adhesion test was performed using a glass test tube instead of the tooth surface.

【0021】(i) Streptococcus mutans 菌に対する歯
垢(菌)付着抑制作用 まず、Streptococcus mutans菌 MT8148株(血清
型c)を含有するブレインハートインフュージョン液体
培地(BHI培地)の一晩培養液30μlを1%ショ糖
を含むBHI培地3ml(滅菌済みの蓋付試験管)に添
加し、この中にケイヒの樹皮抽出液(ケイヒ成分乾燥換
算で1g/ml含有)(以下、これを「ケイヒ抽出液」
とする)を各種の濃度割合で配合して、試験管を30度
に傾けて37℃で18時間静置培養した。
[0021] The (i) Streptococcus mutans plaque against bacteria (bacteria) adhesion prevention effect First, overnight cultures 30μl of Streptococcus mutans bacteria MT8148 strain brain heart infusion liquid medium containing (serotype c) (BHI medium) It was added to 3 ml of BHI medium containing 1% sucrose (sterilized test tube with a lid), and the bark extract of cinnamon bark (containing 1 g / ml in terms of cinnamon component dry matter) was added thereto. "
) Were mixed at various concentration ratios, and the test tube was incubated at 37 ° C. for 18 hours at an angle of 30 °.

【0022】なお、ケイヒ抽出液は、日本薬局方「ケイ
ヒ」の細切10kgを原料に、30%エタノール水溶液
を浸出剤として用いて、日本薬局方・製剤総則・流エキ
ス剤の製法に準じて次のように調製した。すなわち、日
本薬局方「ケイヒ」の細切10kgを、第1浸出剤(3
0%エタノール水溶液)によく混和して密閉状態で室温
で2日間放置した。これを浸出器に密に詰めて、浸出器
の下口を開いた後、ケイヒが覆われるまで徐々に上から
新たに第2浸出剤(30%エタノール水溶液)を加え、
浸出液が滴下し始めたとき、下口を閉じて密閉し、室温
で2〜3日間放置した後、毎分0.5〜1mLの速度で
浸出液を流出させた。最初に得た8.5Lを第1浸出液
として別に保存し、更に浸出液に第2浸出剤を追加して
流出を続け、第2浸出液とした。次いで、第2浸出液を
濃縮して第1浸出液と合わせ、第2浸出剤を加えて10
Lとして、2日間放置した後、上澄液をとった。得られ
た抽出物1mlは原ケイヒ(乾燥物)1gに相当するも
のであった。
The extract of caffeine extract was prepared according to the method of Japanese Pharmacopoeia, General Rules for Pharmaceutical Preparations and General Extract, using 10 kg of finely cut pieces of Caffeine of the Japanese Pharmacopoeia as raw materials and a 30% aqueous ethanol solution as a leaching agent. It was prepared as follows. That is, 10 kg of fine pieces of Japanese Pharmacopoeia "Keihi" were
(0% ethanol aqueous solution), and allowed to stand at room temperature for 2 days in a sealed state. This is densely packed in a leaching device, and after opening the lower opening of the leaching device, a second leaching agent (30% aqueous ethanol solution) is gradually added from the top until the cabbage is covered.
When the leachate began to drip, the lower mouth was closed and sealed, allowed to stand at room temperature for 2 to 3 days, and the leachate was allowed to flow out at a rate of 0.5 to 1 mL per minute. The first obtained 8.5 L was separately stored as a first leachate, and a second leachate was further added to the leachate to continue the outflow to obtain a second leachate. The second leachate is then concentrated and combined with the first leachate, and the second leachate is added to
After standing for 2 days as L, the supernatant was taken. 1 ml of the obtained extract corresponded to 1 g of original cinnamon (dry matter).

【0023】次いで、18時間培養後、試験管を30度
の角度のままゆっくり3回転させ、培養液を空の試験管
にゆっくりデカンテーションした(サンプル1)。試験
管内側表面に歯垢(菌)が付着している空の試験管に上
記1%ショ糖含有BHI培地3mlを入れて、ボルテッ
クスミキサーにより攪拌して試験管内側表面の歯垢
(菌)付着物の一部を洗浄溶出させ、歯垢(菌)溶出物
を含む培養液を空の試験管にデカンテーションした(サ
ンプル2)。次いで、得られた歯垢(菌)付着物試験管
に再度1%ショ糖含有BHI培地3mlを入れ、試験管
内表面に強固に付着した歯垢(菌)をスパーテルで擦り
落としてその溶液をサンプル3とした。なお、上記操作
のうち、ボルテックス攪拌操作は口をゆすぐことを想定
したものである。つまり、サンプル2は口をゆすぐ程度
でとれる歯垢(菌)を反映するものであり、またサンプ
ル3は口をゆすぐ程度ではとれない歯垢(菌)を反映す
るものである。
Next, after culturing for 18 hours, the test tube was slowly rotated three times while keeping the angle of 30 °, and the culture solution was slowly decanted into an empty test tube (sample 1). 3 ml of the above-mentioned 1% sucrose-containing BHI medium is placed in an empty test tube having plaque (fungi) adhered to the inside surface of the test tube, and the mixture is stirred with a vortex mixer to attach plaque (fungus) on the inside surface of the test tube. A part of the kimono was washed and eluted, and the culture solution containing the plaque (bacteria) eluate was decanted into an empty test tube (sample 2). Then, 3 ml of 1% sucrose-containing BHI medium was again added to the obtained plaque (bacteria) attached test tube, the plaque (bacteria) firmly adhered to the inner surface of the test tube was scraped off with a spatula, and the solution was sampled. It was set to 3. Note that, of the above operations, the vortex stirring operation is based on the assumption that the mouth is rinsed. That is, sample 2 reflects plaque (fungi) that can be taken with a mouth rinse, and sample 3 reflects plaque (fungi) that cannot be taken with a mouth rinse.

【0024】さらに、各サンプル溶液に含まれる菌体量
を溶液の濁度(OD:吸光度550nm)を測定するこ
とにより求めた。次いで、溶液の濁度から下式により歯
垢(菌)付着率を求め、かかる付着率(%)に基づいて
ケイヒ抽出液の歯垢(菌)付着抑制作用を評価した。
Further, the amount of cells contained in each sample solution was determined by measuring the turbidity (OD: absorbance 550 nm) of the solution. Next, the plaque (bacteria) adhesion rate was determined from the turbidity of the solution according to the following equation, and the plaque (bacterium) adhesion suppression effect of the caffeine extract was evaluated based on the adhesion rate (%).

【0025】[0025]

【数1】 (Equation 1)

【0026】結果を表1に示す。The results are shown in Table 1.

【0027】またコントロールとして、試験管にケイヒ
抽出液を加えないで(ケイヒ抽出物濃度:0μl/3ml)
上記と同様に実験に行った場合の歯垢(菌)付着率、並
びに比較例としてケイヒ抽出液に代えて、トチュウ(Eu
cammia ulmoides Oliver)の樹皮を同様に抽出したもの
を用いて同様に実験を行った場合の歯垢(菌)付着率に
ついても併せて表1に示す。
As a control, do not add the caffeine extract to the test tube (concentration of caffeine extract: 0 μl / 3 ml).
The plaque (bacteria) adhesion rate when the experiment was performed in the same manner as above, and as a comparative example, Eucalyptus ( Eu
Table 1 also shows the plaque (bacteria) adhesion rate when the same experiment was performed using the bark of cammia ulmoides Oliver).

【0028】[0028]

【表1】 [Table 1]

【0029】(ii) Streptococcus sobrinus 菌に対する
歯垢(菌)付着抑制作用Streptococcus sobrinus 6715株(血清型g)につ
いても上記(i)と同様にして歯垢(菌)付着抑制試験を
行い、ケイヒ抽出物の歯垢(菌)付着抑制作用を評価し
た。結果を表2に示す。
(Ii) Inhibitory effect on plaque (bacteria) adhesion to Streptococcus sobrinus bacteria The plaque (bacteria) adhesion inhibition test was also performed on Streptococcus sobrinus strain 6715 (serotype g) in the same manner as in (i) above, and Cahi extract was extracted. The plaque (bacteria) adhesion inhibitory action of the product was evaluated. Table 2 shows the results.

【0030】[0030]

【表2】 [Table 2]

【0031】以上の結果から、ケイヒ抽出物は歯垢
(菌)付着抑制作用を有しており、有効な抗う蝕剤とな
ることがわかった。
From the above results, it was found that the cabbage extract has an effect of inhibiting plaque (bacteria) adhesion and is an effective anti-carious agent.

【0032】(b)オウヒ抽出物 オウヒ抽出物の抗う蝕作用を、上記(a)(i)及び(ii)
と同様にして、歯垢(菌)付着抑制試験を行うことによ
り評価したなお、オウヒ抽出物はさくらの樹皮を用いて
次のようにして調製した。すなわち、オウヒ(バラ科植
物、ヤマザクラPrunus jamasakura siebold.の皮部を剥
いで乾燥させたもの)の粗粉末に常水を加えて時々かき
混ぜながら3日間水浸してろ過し、得られたろ液に炭酸
石灰(1%)を加えてよくかき混ぜながら更に3日間放
置した。これをろ過して得られたろ液にエタノールを加
えて最終調製品のアルコール濃度を25%に調整してオ
ウヒ流エキスを調製した。得られた抽出物1mlは原オ
ウヒ(乾燥物)1gに相当するものであった。
(B) Spruce extract The anticariogenic effect of the spruce extract was determined by the above (a) (i) and (ii)
In the same manner as described above, evaluation was performed by performing a plaque (fungus) adhesion suppression test. The spruce extract was prepared as follows using cherry bark. That is, the crude powder of spruce (Rosaceae plant, Prunus jamasakura siebold., Peeled and dried) was mixed with ordinary water, soaked in water for 3 days with occasional stirring, and filtered, and the resulting filtrate was carbonated lime. (1%) was added, and the mixture was left for 3 days while stirring well. Ethanol was added to the filtrate obtained by filtering this to adjust the alcohol concentration of the final preparation to 25% to prepare a spruce extract. 1 ml of the obtained extract corresponded to 1 g of raw spruce (dry matter).

【0033】(i) Streptococcus mutans 菌に対する歯
垢(菌)付着抑制作用、及び(ii) Streptococcus sobri
nus 菌に対する歯垢(菌)付着抑制作用を示す結果をそ
れぞれ表3及び表4に示す。
(I) an inhibitory effect on plaque (fungus) adhesion to Streptococcus mutans bacteria, and (ii) a Streptococcus sobri.
Tables 3 and 4 show the results showing the plaque (bacteria) adhesion inhibitory effect on the Nus bacteria, respectively.

【0034】[0034]

【表3】 [Table 3]

【0035】[0035]

【表4】 [Table 4]

【0036】以上の結果から、オウヒ抽出物は歯垢
(菌)付着抑制作用を有しており、有効な抗う蝕剤とな
ることがわかった。実施例 以下、本発明の抗う蝕剤の適用例を実施例として記載す
る。なお、各処方の単位は特に言及しない限り、重量部
を意味するものである。
From the above results, it was found that the spruce extract has an effect of inhibiting plaque (bacteria) adhesion and is an effective anti-carious agent. Examples Hereinafter, application examples of the anti-caries agent of the present invention will be described as examples. The unit of each prescription means part by weight unless otherwise specified.

【0037】 [0037]

【0038】実施例3 糖衣タブレット 錠剤部分200重量部を、糖衣部130重量部で糖衣した口中
清涼剤を作成した
Example 3 Sugar-Coated Tablet A mouthwash was prepared by coating 200 parts by weight of a tablet portion with 130 parts by weight of a sugar-coated portion.

【0039】 [0039]

【0040】 [0040]

【0041】 [0041]

【0042】 [0042]

【0043】 [0043]

【0044】 [0044]

【0045】 実施例10 口腔用パスタ 流動パラフィン 13.00 セタノール 10.00 グリセリン 25.00 ソルビタンモノパルミテート 0.60 ポリオキシエチレンソルビタンモノステアレート 5.00 ラウリル硫酸ナトリウム 0.10 塩化ベンゾトニウム 0.10 サリチル酸メチル 0.10 サッカリン 0.20 香料 0.25 ケイヒ抽出物 0.50 水 残部 計 100.00 Example 10 Oral Pasta Liquid Paraffin 13.00 Cetanol 10.00 Glycerin 25.00 Sorbitan Monopalmitate 0.60 Polyoxyethylene Sorbitan Monostearate 5.00 Sodium Lauryl Sulfate 0.10 Benzotonium Chloride 0.10 Methyl Salicylate 0.10 Saccharin 0.20 Fragrance 0.25 Caffeine Extract 0.50 Water Residue Total 100.00

フロントページの続き (72)発明者 吉井 記与子 大阪府大阪市淀川区三津屋南3−13−35 小林製薬株式会社内 Fターム(参考) 4C083 AA072 AA111 AA112 AA122 AB222 AB282 AB292 AB322 AB472 AC012 AC022 AC072 AC102 AC122 AC132 AC242 AC302 AC312 AC402 AC432 AC442 AC482 AC542 AC582 AC692 AC782 AC862 AD212 AD222 AD272 AD302 AD352 AD412 CC41 DD12 DD15 DD22 DD23 DD27 EE32 4C088 AB33 AB52 AC06 BA08 BA09 BA10 NA14 ZA67 Continuation of the front page (72) Inventor Noriyoshi Yoshii 3-13-35, Mitsujinaminami, Yodogawa-ku, Osaka-shi, Osaka F-term (reference) 4C083 AA072 AA111 AA112 AA122 AB222 AB282 AB292 AB322 AB472 AC012 AC022 AC072 AC102 AC122 AC132 AC242 AC302 AC312 AC402 AC432 AC442 AC482 AC542 AC582 AC692 AC782 AC862 AD212 AD222 AD272 AD302 AD352 AD412 CC41 DD12 DD15 DD22 DD23 DD27 EE32 4C088 AB33 AB52 AC06 BA08 BA09 BA10 NA14 ZA67

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】ケイヒまたはオウヒの抽出物を有効成分と
して含有する抗う蝕剤。
1. An anti-cariogenic agent comprising an extract of cinnamon or spruce as an active ingredient.
【請求項2】請求項1記載の抗う蝕剤を含有する口腔用
組成物。
2. An oral composition comprising the anti-cariogenic agent according to claim 1.
JP26900499A 1999-09-22 1999-09-22 Anti-dental caries agent Pending JP2001089385A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP26900499A JP2001089385A (en) 1999-09-22 1999-09-22 Anti-dental caries agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP26900499A JP2001089385A (en) 1999-09-22 1999-09-22 Anti-dental caries agent

Publications (1)

Publication Number Publication Date
JP2001089385A true JP2001089385A (en) 2001-04-03

Family

ID=17466336

Family Applications (1)

Application Number Title Priority Date Filing Date
JP26900499A Pending JP2001089385A (en) 1999-09-22 1999-09-22 Anti-dental caries agent

Country Status (1)

Country Link
JP (1) JP2001089385A (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003081800A (en) * 2001-09-07 2003-03-19 Kobayashi Pharmaceut Co Ltd Anti-periodontitis agent
KR100489267B1 (en) * 2002-11-27 2005-05-17 유효경 Oral care composition comprising nanoparticulated cinnamon extract
JP2006199661A (en) * 2005-01-24 2006-08-03 Sunstar Inc Coaggregation inhibitor
JPWO2005027893A1 (en) * 2003-09-19 2006-11-24 大塚製薬株式会社 Human β-defensin secretion promoter
KR100916910B1 (en) 2007-12-07 2009-09-09 재단법인 서울보건연구재단 Natural Powder Toothpaste
JP2012214402A (en) * 2011-03-31 2012-11-08 Kobayashi Pharmaceutical Co Ltd Composition for oral cavity
KR101293066B1 (en) 2011-02-11 2013-08-07 더마텍코리아(주) A functional composition with pharmacological activity and a cosmetic composition, an oral cleansing composition and a hair care composition comprising the same
WO2015152416A1 (en) * 2014-04-04 2015-10-08 国立大学法人東北大学 Ocular hypotensive agent
KR20200077090A (en) * 2018-12-20 2020-06-30 동의대학교 산학협력단 Composition for prevention or treatment of dental disease comprising an extract of cinnamon

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03120209A (en) * 1989-10-04 1991-05-22 Kikkoman Corp Cariostatic agent
JPH0625000A (en) * 1992-03-30 1994-02-01 Sunstar Inc Protease inhibitor

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03120209A (en) * 1989-10-04 1991-05-22 Kikkoman Corp Cariostatic agent
JPH0625000A (en) * 1992-03-30 1994-02-01 Sunstar Inc Protease inhibitor

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003081800A (en) * 2001-09-07 2003-03-19 Kobayashi Pharmaceut Co Ltd Anti-periodontitis agent
KR100489267B1 (en) * 2002-11-27 2005-05-17 유효경 Oral care composition comprising nanoparticulated cinnamon extract
JPWO2005027893A1 (en) * 2003-09-19 2006-11-24 大塚製薬株式会社 Human β-defensin secretion promoter
JP4847756B2 (en) * 2003-09-19 2011-12-28 大塚製薬株式会社 Human β-defensin secretion promoter
JP2006199661A (en) * 2005-01-24 2006-08-03 Sunstar Inc Coaggregation inhibitor
KR100916910B1 (en) 2007-12-07 2009-09-09 재단법인 서울보건연구재단 Natural Powder Toothpaste
KR101293066B1 (en) 2011-02-11 2013-08-07 더마텍코리아(주) A functional composition with pharmacological activity and a cosmetic composition, an oral cleansing composition and a hair care composition comprising the same
JP2012214402A (en) * 2011-03-31 2012-11-08 Kobayashi Pharmaceutical Co Ltd Composition for oral cavity
WO2015152416A1 (en) * 2014-04-04 2015-10-08 国立大学法人東北大学 Ocular hypotensive agent
KR20200077090A (en) * 2018-12-20 2020-06-30 동의대학교 산학협력단 Composition for prevention or treatment of dental disease comprising an extract of cinnamon
KR102141623B1 (en) 2018-12-20 2020-08-05 동의대학교 산학협력단 Composition for prevention or treatment of dental disease comprising an extract of cinnamon

Similar Documents

Publication Publication Date Title
JP4948044B2 (en) Plaque formation inhibitor or anti-cariogenic agent
JPS5929620A (en) Preventing agent for carious tooth
JPS647964B2 (en)
JP2001089385A (en) Anti-dental caries agent
JP2003081800A (en) Anti-periodontitis agent
JP2001089345A (en) Anti-dental caries agent
JP2001089386A (en) Anti-dental caries agent
KR20220110700A (en) Oral composition
JP2001089344A (en) Anti-dental caries agent
JP2603465B2 (en) Oral composition
JP2001097835A (en) Dental caries inhibitor
JPS6258329B2 (en)
JPH0495020A (en) Enzyme inhibitor
JP2004002267A (en) Collagenase inhibitor and its utilization
JP3319748B2 (en) Caries inhibitor
JP2002104983A (en) Anticariogenic agent
JP3281716B2 (en) Glucosyltransferase inhibitors, oral preparations and foods and drinks
JP2001097837A (en) Dental caries inhibitor
JPH07309733A (en) Composition for oral cavity
JP2002104986A (en) Periodontal disease medicine
JP2001097875A (en) Anti-teeth-decaying agent
JP2001278801A (en) Cariostatic agent
JP2763824B2 (en) Oral composition
JP3281458B2 (en) Glucosyltransferase inhibitors
JP2001278800A (en) Cariostatic agent

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060922

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100303

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100428

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100526